From: Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications
Index/groups | Normal | P(AAPBA-b-PTE)2 | ||
---|---|---|---|---|
10Â mg/kg/d | 50Â mg/kg/d | 100Â mg/kg/d | ||
RBC (× 106 µl−1) | 10.42 ± 0.45 | 10.35 ± 0.68 | 10.38 ± 0.46 | 10.51 ± 0.34 |
MCV (fL) | 41.56 ± 1.06 | 40.89 ± 0.98 | 41.23 ± 1.14 | 41.68 ± 1.14 |
RDW(%CV) | 17.95 ± 2.54 | 18.01 ± 2.34 | 18.12 ± 2.18 | 18.24 ± 2.21 |
HCT (vol.%) | 43.0 3 ± 2.01 | 42.80 ± 1.86 | 42.95 ± 2.04 | 43.01 ± 1.95 |
MCH (pg) | 13.85 ± 0.86 | 13.80 ± 0.78 | 13.92 ± 0.65 | 13.95 ± 0.62 |
MCHC (g/L) | 33.40 ± 1.53 | 33.80 ± 1.68 | 33.50 ± 1.48 | 33.62 ± 1.54 |
WBC (× 103 µl−1) | 7.95 ± 1.25 | 7.80 ± 1.15 | 8.02 ± 0.95 | 7.90 ± 1.20 |
NE (%) | 18.22 ± 2.57 | 18.24 ± 2.38 | 18.19 ± 2.26 | 18.12 ± 2.12 |
EO (%) | 2.72 ± 1.18 | 2.70 ± 1.22 | 2.74 ± 1.12 | 2.70 ± 1.20 |
BA (%) | 1.80 ± 0.64 | 1.79 ± 0.58 | 1.81 ± 0.70 | 1.78 ± 0.54 |
LY (%) | 74.01 ± 3.09 | 74.31 ± 2.85 | 73.69 ± 2.92 | 74.19 ± 2.68 |
MO (%) | 2.38 ± 0.58 | 2.40 ± 0.37 | 2.35 ± 0.65 | 2.34 ± 0.50 |
PLT (103/mm3) | 768.20 ± 150.80 | 770.35 ± 145.54 | 776.25 ± 153.40 | 765.38 ± 148.26 |
MPV (fL) | 6.01 ± 1.78 | 5.98 ± 1.69 | 6.04 ± 1.70 | 6.03 ± 0.26 |